CWC15 | OmnibusX

I. Expression across cell types

Name	Number of supported studies	Average coverage
B cell	24 studies	21% ± 8%	Explore
natural killer cell	22 studies	22% ± 7%	Explore
regulatory T cell	18 studies	22% ± 4%	Explore
endothelial cell	17 studies	27% ± 12%	Explore
macrophage	14 studies	24% ± 10%	Explore
CD4-positive, alpha-beta T cell	14 studies	24% ± 9%	Explore
CD8-positive, alpha-beta T cell	14 studies	24% ± 8%	Explore
T cell	13 studies	21% ± 6%	Explore
fibroblast	13 studies	28% ± 10%	Explore
classical monocyte	12 studies	24% ± 10%	Explore
naive B cell	12 studies	20% ± 5%	Explore
pericyte	12 studies	23% ± 7%	Explore
smooth muscle cell	12 studies	21% ± 7%	Explore
memory B cell	12 studies	21% ± 3%	Explore
non-classical monocyte	11 studies	28% ± 15%	Explore
conventional dendritic cell	11 studies	25% ± 14%	Explore
endothelial cell of lymphatic vessel	10 studies	25% ± 8%	Explore
naive thymus-derived CD8-positive, alpha-beta T cell	10 studies	23% ± 7%	Explore
CD16-positive, CD56-dim natural killer cell, human	10 studies	24% ± 4%	Explore
mature NK T cell	10 studies	20% ± 2%	Explore
epithelial cell	10 studies	35% ± 20%	Explore
plasmacytoid dendritic cell	10 studies	24% ± 8%	Explore
gamma-delta T cell	10 studies	26% ± 13%	Explore
CD8-positive, alpha-beta memory T cell	9 studies	24% ± 6%	Explore
naive thymus-derived CD4-positive, alpha-beta T cell	9 studies	23% ± 6%	Explore
CD16-negative, CD56-bright natural killer cell, human	9 studies	22% ± 4%	Explore
monocyte	9 studies	19% ± 3%	Explore
ciliated cell	9 studies	28% ± 12%	Explore
myofibroblast cell	8 studies	22% ± 5%	Explore
connective tissue cell	8 studies	26% ± 7%	Explore
mucosal invariant T cell	8 studies	20% ± 3%	Explore
mast cell	7 studies	19% ± 4%	Explore
CD4-positive, alpha-beta memory T cell	7 studies	22% ± 5%	Explore
abnormal cell	7 studies	24% ± 7%	Explore
basal cell	7 studies	29% ± 15%	Explore
effector memory CD8-positive, alpha-beta T cell	6 studies	27% ± 10%	Explore
capillary endothelial cell	6 studies	21% ± 3%	Explore
T follicular helper cell	6 studies	20% ± 2%	Explore
hematopoietic precursor cell	5 studies	29% ± 14%	Explore
effector CD8-positive, alpha-beta T cell	5 studies	20% ± 3%	Explore
progenitor cell	5 studies	20% ± 5%	Explore
epithelial cell of proximal tubule	5 studies	22% ± 4%	Explore
endothelial cell of artery	5 studies	19% ± 4%	Explore
precursor B cell	5 studies	27% ± 10%	Explore
innate lymphoid cell	5 studies	18% ± 2%	Explore
endothelial cell of vascular tree	5 studies	22% ± 4%	Explore
plasmablast	4 studies	43% ± 15%	Explore
pancreatic A cell	4 studies	31% ± 8%	Explore
leukocyte	4 studies	24% ± 7%	Explore
exhausted T cell	4 studies	27% ± 13%	Explore
kidney loop of Henle epithelial cell	4 studies	22% ± 6%	Explore
vein endothelial cell	4 studies	21% ± 4%	Explore
myeloid cell	4 studies	28% ± 10%	Explore
plasma cell	4 studies	32% ± 12%	Explore
pro-B cell	4 studies	25% ± 3%	Explore
astrocyte	4 studies	24% ± 13%	Explore
secretory cell	4 studies	23% ± 7%	Explore
neuron	4 studies	32% ± 18%	Explore
effector memory CD4-positive, alpha-beta T cell	4 studies	27% ± 15%	Explore
dendritic cell	4 studies	43% ± 26%	Explore
type B pancreatic cell	3 studies	41% ± 5%	Explore
kidney distal convoluted tubule epithelial cell	3 studies	26% ± 8%	Explore
mesothelial cell	3 studies	33% ± 19%	Explore
neural crest cell	3 studies	29% ± 5%	Explore
lymphocyte	3 studies	24% ± 8%	Explore
club cell	3 studies	24% ± 7%	Explore
immature B cell	3 studies	21% ± 2%	Explore
type I pneumocyte	3 studies	30% ± 5%	Explore
type II pneumocyte	3 studies	28% ± 12%	Explore
amacrine cell	3 studies	39% ± 13%	Explore
Mueller cell	3 studies	30% ± 8%	Explore
erythroblast	3 studies	39% ± 15%	Explore
intermediate monocyte	3 studies	33% ± 20%	Explore
glutamatergic neuron	3 studies	26% ± 9%	Explore
pancreatic ductal cell	3 studies	44% ± 12%	Explore
granulocyte	3 studies	21% ± 4%	Explore
enteroendocrine cell	3 studies	29% ± 14%	Explore
goblet cell	3 studies	28% ± 12%	Explore
intestinal crypt stem cell	3 studies	21% ± 3%	Explore
double negative thymocyte	3 studies	37% ± 17%	Explore
hematopoietic stem cell	3 studies	19% ± 1%	Explore

II. Expression across tissues

Name	Number of supported studies	Average coverage
peripheral blood	14 studies	24% ± 8%	Explore
lung	9 studies	25% ± 8%	Explore
kidney	7 studies	19% ± 3%	Explore
intestine	6 studies	23% ± 11%	Explore
brain	6 studies	22% ± 5%	Explore
bone marrow	5 studies	20% ± 2%	Explore
eye	4 studies	28% ± 12%	Explore
uterus	4 studies	24% ± 13%	Explore
liver	4 studies	28% ± 19%	Explore
pancreas	3 studies	37% ± 3%	Explore
lymph node	3 studies	22% ± 1%	Explore

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
adrenal gland	100%	2405.73	258 / 258	100%	58.94	230 / 230
brain	100%	2700.56	2642 / 2642	100%	79.49	705 / 705
breast	100%	2530.51	459 / 459	100%	60.17	1118 / 1118
esophagus	100%	2150.24	1445 / 1445	100%	40.48	183 / 183
kidney	100%	2444.75	89 / 89	100%	59.62	901 / 901
liver	100%	1562.63	226 / 226	100%	47.77	406 / 406
ovary	100%	2655.00	180 / 180	100%	60.91	430 / 430
prostate	100%	2313.83	245 / 245	100%	63.63	502 / 502
thymus	100%	2393.26	653 / 653	100%	78.15	605 / 605
uterus	100%	2450.68	170 / 170	100%	72.08	459 / 459
lung	100%	1983.23	577 / 578	100%	55.28	1155 / 1155
pancreas	100%	1312.91	327 / 328	100%	52.61	178 / 178
bladder	100%	2123.57	21 / 21	100%	59.33	502 / 504
stomach	100%	1736.62	359 / 359	99%	45.54	284 / 286
intestine	100%	2178.28	966 / 966	99%	48.82	523 / 527
skin	100%	2202.66	1807 / 1809	99%	55.11	465 / 472
adipose	100%	2468.03	1204 / 1204	0%	0	0 / 0
lymph node	0%	0	0 / 0	100%	77.82	29 / 29
muscle	100%	3441.15	803 / 803	0%	0	0 / 0
spleen	100%	2310.75	241 / 241	0%	0	0 / 0
tonsil	0%	0	0 / 0	100%	47.50	45 / 45
ureter	0%	0	0 / 0	100%	34.52	1 / 1
blood vessel	100%	1991.89	1334 / 1335	0%	0	0 / 0
heart	99%	2149.51	853 / 861	0%	0	0 / 0
eye	0%	0	0 / 0	98%	43.91	78 / 80
peripheral blood	79%	1365.26	736 / 929	0%	0	0 / 0
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0

III. Associated gene sets

GO_0000398	Biological process	mRNA splicing, via spliceosome
GO_0045292	Biological process	mRNA cis splicing, via spliceosome
GO_0016607	Cellular component	nuclear speck
GO_0071013	Cellular component	catalytic step 2 spliceosome
GO_0005739	Cellular component	mitochondrion
GO_0005654	Cellular component	nucleoplasm
GO_0071007	Cellular component	U2-type catalytic step 2 spliceosome
GO_0005681	Cellular component	spliceosomal complex
GO_0000974	Cellular component	Prp19 complex
GO_0005634	Cellular component	nucleus
GO_0005515	Molecular function	protein binding
GO_0003723	Molecular function	RNA binding

IV. Literature review

[source]

Gene name	CWC15
Protein name	Spliceosome-associated protein CWC15 homolog
Synonyms	HSPC148 C11orf5 AD-002
Description	FUNCTION: Involved in pre-mRNA splicing as component of the spliceosome . Component of the PRP19-CDC5L complex that forms an integral part of the spliceosome and is required for activating pre-mRNA splicing. As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs (Probable). .
Accessions	ENST00000279839.8 Q9P013

CWC15 report

I. Expression across cell types

II. Expression across tissues

III. Associated gene sets

IV. Literature review